Of note, SRSF2 was linked with poor survival of patients with myelodysplastic syndromes and the frequent mutation of SRSF2 could induce oncogenesis in hematopoietic cells through activating a cascade of alternative splicing [43]. Here, SRSF2 is linked to myelodysplastic syndrome.